GlassScriptPhysician profile
Hal Scherz
NPI 1699879155
$50,674.09
in general payments reported to CMS, 2019-2025
23 companies · $1,240 in 2025
The $1,240 reported for 2025 was more than what 91% of Pediatric Urology providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $37K · 2021: $9,151 · 2022: $934 · 2023: $1,857 · 2024: $608 · 2025: $1,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,130 · Consulting Fee: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,130.35 |
| Consulting Fee | $1,575.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $47,978.13 | 2019-2023 | |
| Teleflex LLC | $1,044.57 | 2024-2025 | Deflux Metal Needle, Deflux, Urolift |
| Boston Scientific Corporation | $867.04 | 2020-2025 | Lithovue, Ams 700, General - Erectile Dysfunction |
| Myovant Sciences INC. | $115.21 | 2021 | |
| Medtronic, INC. | $110.94 | 2024-2025 | Interstim |
| C. R. Bard, INC. & Subsidiaries | $81.46 | 2023-2025 | Bard Urinary Drainage Bag |
| Angiodynamics, INC. | $76.26 | 2022 | |
| Antares Pharma, INC. | $49.82 | 2024 | Xyosted |
| Bracco Diagnostics INC. | $43.24 | 2025 | |
| Novo Nordisk INC | $42.39 | 2024 | |
| Coloplast Corp | $31.68 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $29.58 | 2025 | |
| Integra Lifesciences Corporation | $25.23 | 2023 | Biodrestore, Biodfactor, Medihoney |
| Merck Sharp & Dohme LLC | $24.82 | 2023 | Lynparza, Keytruda |
| Blue Earth Diagnostics | $23.95 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $23.57 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $20.78 | 2022 | |
| Abc Home Medical Supply, INC. | $18.74 | 2022 | |
| Axonics, INC. | $17.29 | 2022 | |
| Janssen Biotech, INC. | $15.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.43 | 2021 | |
| Olympus America INC. | $14.17 | 2025 | Itind System |
| Travere Therapeutics, INC. | $5.13 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hal Scherz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.